Satsuma Pharmaceuticals, Inc.
STSADelisted Jun 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001692830
Satsuma Pharmaceuticals, Inc. was delisted on Jun 8, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 31 institutions reported holding it in 13F filings for Q1 2023, worth $12.7M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Satsuma Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −4 vs. Q1 2022
- Shares held
- 22.8M
- −312.4K (−1.4%) vs. Q1 2022
- Total value
- $94.2M
- +$6.56M (+7.5%) vs. Q1 2022
- New holders
- 3
- 9 more added
- Sold out
- 7
- 8 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 31 | $12.7M |
| Q4 2022 | 33 | $17.8M |
| Q3 2022 | 41 | $146.7M |
| Q2 2022 | 32 | $94.2M |
| Q1 2022 | 36 | $87.7M |
| Q4 2021 | 35 | $103.6M |
| Q3 2021 | 45 | $108.3M |
| Q2 2021 | 60 | $167.4M |
| Q1 2021 | 61 | $136.3M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Satsuma Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 118 | $0 | 0.00% | +9+8.3% | Added |
| Advisor Group Holdings, Inc. | 1,000 | $4.00K | 0.00% | +1,000 | New |
| Citigroup Inc | 7,073 | $29.0K | 0.00% | +7,073 | New |
| Goldman Sachs Group Inc | 10,109 | $42.0K | 0.00% | −26−0.3% | Reduced |
| Schonfeld Strategic Advisors LLC | 11,400 | $47.0K | 0.00% | −10,100−47.0% | Reduced |
| Charles Schwab Investment Management Inc | 12,319 | $52.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 13,669 | $57.0K | 0.00% | −37,405−73.2% | Reduced |
| UBS Group AG | 17,594 | $73.0K | 0.00% | +15,127+613.2% | Added |
| Norges Bank | 17,700 | $73.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 37,600 | $156.0K | 0.00% | −29,000−43.5% | Reduced |
| Northern Trust Corp | 37,935 | $157.0K | 0.00% | −823−2.1% | Reduced |
| State Street Corp | 43,036 | $178.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 46,998 | $195.0K | 0.00% | +46,998 | New |
| Boothbay Fund Management, LLC | 64,840 | $268.0K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 127,300 | $527.0K | 0.01% | +10,000+8.5% | Added |
| BlackRock Inc. | 137,240 | $568.0K | 0.00% | +3,109+2.3% | Added |
| Nan Fung Group Holdings Ltd | 142,900 | $592.0K | 0.41% | 00.0% | Unchanged |
| Citadel Advisors LLC | 150,954 | $624.0K | 0.00% | −34,656−18.7% | Reduced |
| Walleye Capital LLC | 151,428 | $627.0K | 0.02% | −110,385−42.2% | Reduced |
| Geode Capital Management, LLC | 164,738 | $682.0K | 0.00% | +58,368+54.9% | Added |
| Barclays PLC | 202,478 | $838.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 236,535 | $979.0K | 0.00% | +16,671+7.6% | Added |
| Morgan Stanley | 246,692 | $1.02M | 0.00% | +234,307+1,891.9% | Added |
| Vanguard Group Inc | 640,364 | $2.65M | 0.00% | −7,968−1.2% | Reduced |
| Ikarian Capital, LLC | 653,448 | $2.70M | 1.12% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 757,485 | $3.14M | 0.00% | +5,108+0.7% | Added |
| Vivo Capital, LLC | 1,232,394 | $5.10M | 0.51% | 00.0% | Unchanged |
| TPG GP A, LLC | 1,885,939 | $7.81M | 0.12% | 00.0% | Unchanged |
| Samlyn Capital, LLC | 2,944,255 | $12.2M | 0.24% | +149,046+5.3% | Added |
| NEA Management Company, LLC | 3,142,958 | $13.0M | 0.67% | 00.0% | Unchanged |
| Commodore Capital LP | 3,711,286 | $15.4M | 3.25% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 5,914,252 | $24.5M | 0.65% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −473,562−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −81,739−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −69,351−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −2,163−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,782−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −93−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −174−100.0% | Sold out |